VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GMRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GMREGlobal Medical REIT Inc.
$35.74$94M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGMREQuarterly Cash Flow

Global Medical REIT Inc. (GMRE) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Global Medical REIT Inc. (GMRE) quarterly cash flow statement — complete operating, investing & financing history

GMRE Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23
Cash from Operations21.63M17.57M22.14M12.27M20.52M16.3M18.93M14.29M18.13M16.67M17.88M15.77M
Operating CF Growth %5.41%7.75%16.96%-14.14%13.23%-2.18%5.87%-9.37%-1%-9%-23.87%-4.05%
Operating CF / Revenue %61.51%43.31%58.45%35.47%58.72%47.7%55.32%40.76%55.04%46.96%49.18%43.53%
Net Income-6.15M-5.06M585K3.56M2.94M3.2M-1.95M2.31M551K4.83M14.18M2.17M
Depreciation & Amortization15.48M14.36M15.01M13.59M13.89M13.33M14.14M14.23M14.42M14.37M15.06M15.16M
Stock-Based Compensation1.41M1.21M1.73M151K1.28M1.27M1.32M1.23M1.22M1.19M1.15M688K
Other Non-Cash Items16.42M7.12M490K-104K-3.33M-5.17M4.85M765K2.47M-1.45M783K131K
Working Capital Changes-5.53M-58K4.33M-4.93M5.75M3.68M570K-4.25M-536K-2.27M-504K-2.38M
Cash from Investing6.75M-703K-39.23M-27.22M-19.52M-25.49M1.78M-2.72M-3.11M5.66M61.97M3.09M
Acquisitions (Net)0000000000110K792K
Purchase of Investments-204K204K00000000-110K-792K
Sale of Investments10.9M3.02M06.42M013.01M000012.79M3.69M
Other Investing101.11M-77.01M-735K-33.65M30.87M-43.7M4.99M-712K712K9.11M51.15M211K
Cash from Financing-26.33M-16.25M18.72M13.6M153K9.16M-20.7M-10.49M-15.9M-24.5M-84.05M-19.34M
Dividends Paid-15.28M-7.98M-16.69M-16.72M-16.57M-16.37M-16.36M-16.4M-16.27M-16.27M-16.14M-16.15M
Common Dividends0-7.98M-15.23M-15.27M-15.11M-12M-14.9M-14.95M-14.82M-14.82M-14.69M-14.7M
Debt Issuance (Net)0-1000K1000K1000K1000K1000K-1000K1000K-1000K-1000K-1000K-1000K
Share Repurchases-6M00000000000
Other Financing-11.05M-4.37M18K-18K21K-17K312K-64K8.2M-149K-263K-639K
Net Change in Cash2.05M614K1.64M-1.35M1.15M-29K12K1.08M-888K-2.17M-4.2M-474K
Exchange Rate Effect000000000000
Cash at Beginning9.84M9.23M7.59M8.94M7.79M7.82M7.81M6.72M7.61M9.79M13.98M14.46M
Cash at End11.89M9.84M9.23M7.59M8.94M7.79M7.82M7.81M6.72M7.61M9.79M13.98M
Free Cash Flow-88M92.61M-18.32M-22.32M-33.34M21.51M15.73M12.29M14.3M13.22M15.91M14.96M
FCF Growth %-163.91%330.58%-216.47%-281.6%-333.2%62.68%-1.17%-17.87%-12.61%138.31%130.07%274.22%
FCF / Revenue %-250.21%228.32%-48.35%-64.51%-95.4%62.93%45.96%35.04%43.42%37.26%43.77%41.3%